Corcept Therapeutics | CORT - Trade Creditors


Corcept Therapeutics reported $33.31M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 12.25M 1.34M Mar/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Ardelyx USD 28.2M 8.96M Mar/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Canopy Growth CAD 34.82M 14.85M Mar/2026
Corcept Therapeutics USD 33.31M 7.14M Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Lexicon Pharmaceuticals USD 3M 87K Mar/2026
Merck USD 3.86B 541M Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novartis USD 4.32B 134M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 14.01M 1.14M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026